Business Context and Reporting Period
This Form 8-K Current Report, filed on December 11, 2023, covers events occurring on December 10, 2023, for MaxCyte, Inc. (MXCT), a Delaware corporation. The filing primarily addresses significant executive leadership transitions, including the retirement of the Chief Executive Officer and the appointment of a successor.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements and personnel changes.
Material Changes and Executive Transitions
Retirement of Doug Doerfler
- Effective Date: December 31, 2023.
- Roles: President, Chief Executive Officer, and Director.
- Severance Package:
- 18 months of base salary paid in monthly installments starting February 1, 2024.
- COBRA healthcare premium coverage for 18 months.
- Performance-based bonus for 2023, payable by March 15, 2024.
- Consulting Agreement:
- Term: December 31, 2023, through June 30, 2025.
- Fee: $10,000 per month for the first 15 hours of service; $600 per hour thereafter.
- Equity: Unvested stock options vest immediately upon the earliest of the end of the consulting term, early termination by the company, or a Change in Control.
Appointment of Maher Masoud
- Effective Date: January 1, 2024.
- Roles: President, Chief Executive Officer, and Director.
- Compensation Changes:
- Base Salary: Increased from $412,500 to $590,000 annually.
- Target Bonus: Increased from 40% to 60% of base salary.
- Equity Grant: 400,000 stock options (25% vesting on first anniversary, remainder over 36 months).
- Severance Provisions (Change in Control):
- 18 months of base salary plus 1.5x target bonus if terminated within 3 months prior to or 24 months following a Change in Control.
- 12 months of base salary for other qualifying terminations outside the Change in Control window.
- Accelerated vesting of unvested options upon Change in Control-related termination.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, operational outlook, or specific risk factors beyond the standard disclosure that the transition agreements are subject to the execution of releases and board approvals. The company intends to file the full text of the Transition Agreement, Consulting Agreement, and Promotion Letter as exhibits to its Annual Report on Form 10-K for the year ending December 31, 2023.
Investor Verification Checklist
- Verify the exact vesting schedule and exercise price for the 400,000 stock options granted to Maher Masoud once the grant date is finalized.
- Confirm the total cash outflow for Doug Doerfler's 18-month salary continuation and consulting fees in the upcoming fiscal year.
- Review the full text of the Transition and Consulting Agreements in the upcoming Form 10-K for any additional covenants or restrictions not detailed in this summary.
- Monitor the company's press release (Exhibit 99.1) for any strategic rationale regarding the leadership change.